跳至主要内容
临床试验/NCT01860573
NCT01860573已完成不适用

Neurodevelopmental and Growth Outcomes of Early, Aggressive Protein Intake in Very Low Birthweight Infants

Women and Infants Hospital of Rhode Island1 个研究点 分布在 1 个国家目标入组 168 人开始时间: 2008年11月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
168
试验地点
1
主要终点
Number of Participants With Weight<10th Percentile for Age

研究概览

简要总结

The purpose of this study is to determine whether providing increased protein to premature infants in the first week of life allows for better growth during the hospital stay and improved developmental outcomes by age 2.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
— 至 18 Hours(Child)
性别
All
接受健康志愿者

入选标准

  • birth weight 400 to 1250 grams
  • 24 0/7 to 30 6/7 weeks gestational age

排除标准

  • chromosomal, structural, metabolic, endocrine, or renal abnormalities that could affect growth
  • infants >18 hours of age
  • infants in extremis who are unlikely to survive past 72 hours

研究组 & 干预措施

Standard amino acids

Active Comparator

Receive 1-2 gm/kg/day amino acids at birth and advanced by 0.5 gm/kg/day for goal of 4 gm/kg/day

干预措施: Amino acids (Drug)

High amino acids

Experimental

Receive 3-4 gm/kg/day amino acids at birth and advanced to goal of 4 gm/kg/day as soon as possible after birth

干预措施: Amino acids (Drug)

结局指标

主要结局

Number of Participants With Weight<10th Percentile for Age

时间窗: 36 weeks post-conceptual age

Number of Participants With Length <10th Percentile for Age

时间窗: 36 weeks post-conceptual age

Number of Participants With Head Circumference <10th Percentile for Age

时间窗: 36 weeks post-conceptual age

Cognitive Development Score

时间窗: 18-22 months corrected gestational age

Reported as units on a scale with mean of 100 and a Standard Deviation of 15, and range from 40-160. Higher values indicate a better outcome.

次要结局

  • Serum Creatinine(Day of life 1, 2, 3, 5 and 7)
  • Serum Blood Urea Nitrogen(Day of life 1, 2, 3, 5 and 7)
  • Serum Bicarbonate(Day of life 1, 2, 3, 5 and 7)

研究者

发起方
Women and Infants Hospital of Rhode Island
申办方类型
Other
责任方
Principal Investigator
主要研究者

Joseph Bliss

Staff Neonatologist

Women and Infants Hospital of Rhode Island

研究点 (1)

Loading locations...

相似试验

Neurodevelopmental and Growth Outcomes of Early,... | 临床试验